Utility of next‐generation sequencing in the diagnosis of metastatic melanoma: A case report
Journal of Cutaneous Pathology · 2024
DOI: 10.1111/cup.14660 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Saul Turcios Escobar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Illinois Hospital & Health Sciences System, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Ubiquitin Thiolesterase, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
During routine dermatologic examination, a 77‐year‐old male was noted to have a firm blue subcutaneous nodule on his right lateral upper back. His past medical history included metastatic melanoma of unknown primary involving right and left axillary lymph nodes, treated with ipilimumab/nivolumab with complete response, and subsequent primary uveal melanoma. The subcutaneous nodule was located near his previous right axillary scar for metastatic melanoma. Excision of the nodule showed a plexiform neoplasm involving mid and deep dermis composed of spindle and epithelioid atypical cells admixed with numerous melanophages. Central necrosis was present. Immunohistochemical studies revealed the tumor cells to be diffusely positive for HMB45, with retained expression of BAP1 and p16. The tumor cells were negative for PRAME, nuclear expression of β‐catenin, LEF1, and BRAF V600E. Molecular studies demonstrated BAP1 and GNA11 somatic mutations, a profile different from that exhibited by his prior melanoma. Collectively, these data were interpreted as a metastasis from uveal melanoma and not a recurrence of his metastatic likely cutaneous melanoma after complete response to immunotherapy. This case emphasizes the importance of molecular studies for definitive diagnosis in challenging clinical situations, especially when there is discordance among histopathological, immunohistochemical, and molecular studies. Integration of clinical, histopathological, and molecular features is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Illinois Hospital & Health Sciences System, Chicago, Illinois, USA.
- Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Saul Turcios Escobar, Richard Yang, Phyu P Aung, Carlos A Torres-Cabala
Zitieren
APA
Turcios Escobar, S., Yang, R., Nelson, K. C., Gershenwald, J. E., Tawbi, H., Aung, P. P., Patel, S. P., & Torres-Cabala, C. A. (2024). Utility of next‐generation sequencing in the diagnosis of metastatic melanoma: A case report. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14660
Vancouver
Turcios Escobar S, Yang R, Nelson KC, Gershenwald JE, Tawbi H, Aung PP, et al. Utility of next‐generation sequencing in the diagnosis of metastatic melanoma: A case report. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14660
BibTeX
@article{TurciosEscobar2024,
author = {Turcios Escobar, Saul and Yang, Richard and Nelson, Kelly C and Gershenwald, Jeffrey E and Tawbi, Hussein and Aung, Phyu P and Patel, Sapna P and Torres-Cabala, Carlos A},
title = {Utility of next‐generation sequencing in the diagnosis of metastatic melanoma: A case report},
journal = {Journal of Cutaneous Pathology},
year = {2024},
doi = {10.1111/cup.14660}
}
EUVIMED